Ao. Stemmerrachamimov et al., UNIVERSAL ABSENCE OF MERLIN, BUT NOT OTHER ERM FAMILY MEMBERS, IN SCHWANNOMAS, The American journal of pathology, 151(6), 1997, pp. 1649-1654
NF2 (neurofibromatosis 2, encoding the merlin protein) gene mutations
and chromosome 22q loss have been demonstrated in the majority of spor
adic and NF2-associated schwannomas, but many schwannomas fail to demo
nstrate genetic evidence of biallelic NF2 gene inactivation, In additi
on, the role of the merlin-related ERM family members (ezrin, radixin,
and moesin) remains unclear in these tumors. We therefore studied exp
ression of NF2-encoded merlin as well as ezrin, radixin, and moesin in
22 vestibular and peripheral schwannomas that had been evaluated for
NF2 mutations and chromosome 22q loss. Western blotting and immunohist
ochemistry with antibodies directed against the amino and carboxy term
ini of merlin demonstrated loss of merlin expression in all studied sc
hwannomas, including 12 tumors lacking genetic evidence of biallelic N
F2 gene inactivation, Western blotting with antibodies directed agains
t ezrin, radixin, and moesin, however, showed expression of these prot
eins in all schwannomas. In addition, immunohistochemistry with an ant
ibody to moesin revealed widespread expression in tumor and endothelia
l cells. These data indicate that the specific loss of merlin is unive
rsal to schwannomas and is not licked to loss of ezrin, radixin, or mo
esin expression.